🔜 🧠
“We are about to enter the era of interventional psychiatry, transforming the field of psychiatry.” — Tom Insel, former NIMH Director, at a recent psychedelic science conference.

We have invested in many of these new modalities: transcranial focused ultrasound (Sanmai), minimally invasive deep brain stimulation and vagus nerve stimulation (Neurobionics), brain-computer-interfaces (Neuralink), auditory dream engineering (Dust), psychedelic-assisted therapy (atai/Lilly), and real-world-data collection for all (Osmind).

Insel also co-authored a Nature paper with Osmind defining the field: https://www.nature.com/articles/s44220-026-00708-3.epdf
+ summary: https://www.osmind.org/interventional-psychiatry

Interventional psychiatry companies:
•  tFUS: https://www.Sanm.ai/technology
• Endovascular DBS: https://Neurobionics.io
•  BCI: https://Neuralink.com
•  Dream engineering: https://www.DUST.systems
•  Psychedelics: https://www.ataibeckley.com

P.S. Underfunded: “From 2002-2013, the NIMH did not receive any funding applications for psychedelics. It was all funded and legitimized by philanthropy.”

P.S.S. Needed: “The World Health Organization (WHO) predicts that without significant changes, mental illness will cost the world economy $16t by 2030, making it the largest disease burden globally." — UBS: https://flic.kr/p/2jcRcoS

We need significant changes.